Speaker illustration

Mr Gustavo B Justino

Baia Sul Hospital, Florianopolis (Brazil)

Early initiation of PCSK9 inhibitor therapy versus placebo in patients with acute coronary syndrome: a systematic review and meta-analysis

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Treatment of acute coronary syndromes in clinical practice

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb